Get All Information That You Search Here
Showing posts with label Stubborn. Show all posts
Showing posts with label Stubborn. Show all posts

Thursday, June 9, 2011

Kids with stubborn asthma may have food allergy (Reuters)

NEW YORK (Reuters Health) – Inner-city children with poorly controlled asthma or skin allergies may be more likely to have food allergies, a new study hints.

Researchers found that among 228 inner-city New York children seen at their allergy clinic, 28 percent had a food allergy -- with eggs, peanuts and milk being the prime culprits. By contrast, the rate of food allergy among U.S. kids in general is only about four percent.

And a full 71 percent were "sensitized" to at least one food - meaning they had immune system antibodies in their blood against a particular food. In other words, their body was on the alert, and they were at increased risk of an allergic reaction. That rate too is much higher than average.

Some of the children were tested for food allergies because they had symptoms, such as hives or an itchy rash, breathing difficulty, or nausea, vomiting or diarrhea soon after eating a particular food.

But most -- 62 percent -- had never had any obvious reaction to food. Instead, they were tested because they had asthma or eczema (an allergic skin condition) that was not responding well to medication.

The children in this study were patients at an allergy clinic, so they are not representative of inner-city children in general.

Still, the findings suggest that doctors who treat inner-city children with stubborn asthma or eczema "should have a high degree of suspicion for food allergy," senior researcher Dr. Julie Wang told Reuters Health in an email.

In those cases, she said, doctors should get a detailed history of children's symptoms and refer families to an allergy specialist if necessary.

Wang and her colleagues at the Mount Sinai School of Medicine in New York report the findings in the Journal of Allergy & Clinical Immunology.

It's known that poor minority children, many of whom live in inner cities, have high rates of asthma and nasal allergies. An estimated 23 percent of Puerto Rican children from low-income families have asthma, as do 16 percent of poor African-American children, according to the U.S. Centers for Disease Control and Prevention.

That compares with a national average of just over nine percent.

Wang said she is not aware of any studies that have looked at the prevalence of food allergies among inner-city children.

The rates of food allergy and sensitization in this study were much higher than the national norm: About four percent of U.S. children younger than 18 have a food allergy, while food sensitization affects an estimated 28 percent of children age five and younger -- the age range where it is most common.

Nationally, food allergies are seen as a growing problem. In 2007, about three million school-aged children had a food allergy -- up 18 percent from a decade before. And there is some evidence that children's emergency room visits for severe food reactions are on the upswing as well.

No one is sure why the rate is rising.

One theory blames changes in children's diets. Another theory, known as the "hygiene hypothesis," holds that today's clean living -- creating less exposure to germs -- may actually make some people's immune system more prone to attacking normally harmless substances, like food proteins and pollen.

Regardless of what's behind the trend, the research team says that when inner city children have skin rashes or asthma that can't be controlled with standard medicines, doctors should consider the possibility of food allergy - even if the kids don't show any of the usual reactions to food.

SOURCE: http://bit.ly/kAcHiP Journal of Allergy & Clinical Immunology, online May 8, 2011.

Thursday, June 2, 2011

Drug Halts Growth of Stubborn Breast Cancer Cells (LiveScience.com)


The tricky breast cancer cells that scientists say survive through chemotherapy treatments and sprout new cancer growths elsewhere in the body may soon meet their match.


A new study shows that these cells, called breast cancer stem cells, rely on a certain molecular pathway to survive, and that when this pathway is turned off by a drug, the cells stop dividing.


Not all types of breast cancer have these stem cells, said study researcher Dr. Kornelia Polyak, an associate professor of medicine at Harvard Medical School.


But about 50 percent of the hard-to-treat "triple-negative" breast cancer patients do have them, Polyak said. Triple-negative breast cancers get their name from the fact that they lack three hormone receptors found in other breast cancers.


There are no targeted therapies (which are treatments designed to selectively kill cancer cells) currently approved to treat triple-negative breast cancers, so chemotherapy (which affects many cells in the body) remains the only option, and it does not work for 80 percent of patients, Polyak said.


The new study reveals a way that a targeted therapy might work. The researchers found 15 genes that had higher levels of activity in breast cancer stem cells than in other breast cancer cells. They then found that all these genes played a role in a single pathway in the cells — called the Jak2/Stat3 pathway.


The high level of activity of the genes led the researchers to discover that not only is this pathway activated in breast cancer stem cells, but also that the stem cells need the pathway to be turned on in order to divide.


"When it's off, the tumors stopped growing," and some of the cancer stem cells died, Polyak said. Other cells, which do not have this pathway activated, can survive even if this pathway is blocked. So, the researchers concluded, blocking this pathway with a drug would be a good strategy for selectively halting the growth of these cells.


"Cancer stem cells" are not the same as other stem cells, Polyak noted, they are simply cells within a tumor that seem to give rise to new tumors more easily than other cancer cells do. Because of the many genetic changes that constantly occur in cancer cells, any given cancer cell may become a "cancer stem cell," or can revert back. 


"We're very excited about the findings," Polyak said, because the pathway is not only crucial to the growth of the cancer stem cells, it is also involved with the growth of blood vessels that feed tumors and with the production of inflammation around tumors. By blocking this pathway, she said, "we can hit tumor multiple different ways."


The study was conducted on human breast cancer cells growing in lab dishes and injected into mice to form tumors, so the findings need to be validated in clinical trials done with breast cancer patients.


But drugs that block this pathway, which can be taken orally, are already being tested in several types of blood cancer, so much of initial safety testing has already been done, Polyak said. In fact, a clinical trial is set to begin in patients with triple-negative breast cancer at the Dana-Farber Cancer Institute in Boston later this year, she said.  


Triple-negative breast cancers make up about 15 to 20 percent of breast cancers and tend to occur in younger women, those with BRCA1 gene mutations, and black women.


Pass it on:  Scientists have identified a way to selectively kill breast cancer stem cells.


Follow MyHealthNewsDaily Managing Editor KarenRowan on Twitter @karenjrowan